PT2399 - AN OVERVIEW

PT2399 - An Overview

Indicated as monotherapy for Grownups with HR-favourable, HER2-detrimental State-of-the-art or metastatic breast cancer with disorder progression next endocrine therapy and prior chemotherapy in metastatic placing 200 mg PO BIDSpecified medicines should not be applied at or across the time of having foods or eating specified kinds of food consideri

read more